Evogene (EVGN) Return on Sales (2016 - 2025)
Historic Return on Sales for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to 25.4%.
- Evogene's Return on Sales rose 262500.0% to 25.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 25000.0%. This contributed to the annual value of 0.58% for FY2024, which is 40200.0% up from last year.
- Per Evogene's latest filing, its Return on Sales stood at 25.4% for Q3 2025, which was up 262500.0% from 3.99% recorded in Q2 2025.
- Over the past 5 years, Evogene's Return on Sales peaked at 25.4% during Q3 2025, and registered a low of 55.25% during Q3 2021.
- In the last 5 years, Evogene's Return on Sales had a median value of 10.89% in 2023 and averaged 14.25%.
- Examining YoY changes over the last 5 years, Evogene's Return on Sales showed a top increase of 748100bps in 2021 and a maximum decrease of -381300bps in 2021.
- Over the past 5 years, Evogene's Return on Sales (Quarter) stood at 25.99% in 2021, then soared by 78bps to 5.79% in 2022, then tumbled by -119bps to 12.69% in 2023, then soared by 95bps to 0.61% in 2024, then surged by 4242bps to 25.4% in 2025.
- Its Return on Sales stands at 25.4% for Q3 2025, versus 3.99% for Q2 2025 and 1.22% for Q1 2025.